Resource Library
Showing 1 to 10 of 320 results
Image
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Image
Beyond active surveillance (the ‘watch and wait approach’) there are several CLL treatments to consider. Each treatment has different features and side effects. It is important to be comfortable with the CLL treatment you choose.
Image
Cancer treatments can disrupt sleep. Find out how treatments can affect sleep and what strategies you can use to sleep better.
Image
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Image
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Image
After being diagnosed with leukemia at 21 years old, Shae-Lynn Way shares her experience with shifting her mindset while preparing for a second stem cell transplant after her leukemia returned.
Image
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
Image
In this 1-hour webcast, Dr. Lynda Foltz, University of British Columbia, will review this type of myeloproliferative neoplasm (MPN): its diagnosis, treatment options, and aspects of follow-up care.) People with ET have too many platelets, a type of blood cell. Too many platelets can result in a blood clot (thrombosis) forming in a blood vessel.
Image
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). DLBCL is fast-growing (aggressive) but treatable. It most often appears in older adults but can appear at any age.
Image
Cutaneous T-cell lymphoma (CTCL) is a slow-growing (indolent) subtype of non-Hodgkin lymphoma (NHL). CTCL is rare, representing 4% of NHL cases. It starts in white blood cells (lymphocytes) that reside in the skin, called T-cells.